Health Canada15 Aug 2026
Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline
Health Canada published a recall notice for Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline on 15 Aug 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 15 Aug 2026
- Recall type
- Public advisory
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: Teva Canada Ltd. is recalling two lots of Teva-Pregabalin 150 mg capsules after routine testing identified that some capsules may be contaminated with the drug sertraline. Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure.Anaphylactic reaction symptoms can be fatal and may include:Shortness of breath, wheezing, or difficulty breathingSwelling of the eyelids, face, lips, mouth, tongue, or throatUncontrolled shakingFainting or dizzinessTrouble swallowing or speakingWidespread rash, hivesProducts from the recalled lots were first sold in Canada in September 2025 and expire July 31, 2027.Pregabalin is a prescription drug used in adults to treat pain caused by nerve damage due to diabetes, shingles or spinal cord injury. It is also used to treat pain associated with fibromyalgia.Sertraline is a prescription drug used in adults to relieve symptoms of depression, obsessive-compulsive disorder, and panic disorder. Side effects may include nausea, diarrhea, dry mouth, sleep changes, dizziness, tremors or increased sweating.Health Canada is monitoring the company's recall and implementation of corrective and preventive actions. What you should do What to do: If you experience a serious allergic reaction (anaphylaxis), stop taking the affected product and seek immediate medical help by calling 9-1-1. Otherwise, do not stop taking your pregabalin medication without first speaking with your healthcare professional or pharmacist, as stopping suddenly may cause withdrawal symptoms including insomnia, nausea, headache, anxiety, excessive sweating, diarrhea, and convulsions.Return the product to the pharmacy where it was purchased as soon as possible for a replacement or alternative supply, and for proper disposal. If you are unsure whether your product is recalled, check with your pharmacy.Seek medical attention if you have used this product and think you are experiencing side effects.Contact Teva Canada Customer Care by calling toll-free at 1-800-268-4129 or by email at customer.service@tevacanada.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada. Additional information Details Original published date: 2026-08-15 Affected products: ProductDINLotExpiryTeva-Pregabalin 150 mg capsules02361205100070495100068913July 31, 2027 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.